...
首页> 外文期刊>Journal of Pain Research >Efficacy and safety of 0.75% ropivacaine instillation into subinguinal wound in patients after bilateral microsurgical varicocelectomy: a bi-center, randomized, double-blind, placebo-controlled trial
【24h】

Efficacy and safety of 0.75% ropivacaine instillation into subinguinal wound in patients after bilateral microsurgical varicocelectomy: a bi-center, randomized, double-blind, placebo-controlled trial

机译:双侧精索静脉曲张摘除术后将0.75%罗哌卡因滴入龈下伤口的疗效和安全性:一项双中心,随机,双盲,安慰剂对照试验

获取原文
           

摘要

Objective: To evaluate the efficacy and safety of 0.75% ropivacaine instillation into inguinal wound in patients who have undergone bilateral microsurgical varicocelectomy. Patients and methods: Eighty-five men who were screened for bilateral varicoceles from March 2015 to July 2016 were randomized for the treatment. All patients underwent inguinal varicocelectomy by general anesthesia. After ligation of the internal spermatic veins from the spermatic cord, additional delivery of testis through inguinal incision site was done to ligate external spermatic veins and gubernacular veins. Before repairing external oblique aponeurosis, 6?mL of 0.75% ropivacaine and 6?mL of normal saline were instilled under the fascia and around the funiculus (spermatic cord) by a randomized and double-blind method. Visual analog scale (VAS) pain score and Prince Henry Pain Score (PHPS) were used for evaluating operative sites at 1, 2, 4, and 8?hours and 7?days after surgery. Safety and tolerability were evaluated throughout the course of this study by assessing adverse events. Results: A total of 55 men completed the study. Of these 55 men, 31 received instillation of ropivacaine on the left operative site, while 24 received instillation of ropivacaine on the right operative site. VAS pain scores and PHPS in the ropivacaine-instilled operative site were significantly lower compared to those obtained with placebo at 2, 4, and 8?hours after surgery. In general, instillation of ropivacaine was safe and well tolerated in patients. Conclusion: Ropivacaine instillation into inguinal surgical site wound significantly reduced postoperative pain after microsurgical varicocelectomy.
机译:目的:评价0.75%罗哌卡因滴入腹股沟伤口对双侧显微精索静脉曲张切除术的疗效和安全性。患者和方法:从2015年3月至2016年7月筛查双侧精索静脉曲张的八十五名男性被随机分配接受治疗。所有患者均在全身麻醉下进行腹股沟静脉曲张切除术。从精索结扎精索内静脉后,通过腹股沟切开部位进行额外的睾丸递送,以结扎精索外和gubernacular静脉。在修复外斜肌腱膜炎之前,通过随机和双盲方法在筋膜下和真菌(精索)周围滴入6?mL 0.75%罗哌卡因和6?mL生理盐水。视觉模拟量表(VAS)疼痛评分和亨利王子疼痛评分(PHPS)用于评估手术后1、2、4、8、7和7天的手术部位。在整个研究过程中,通过评估不良事件来评估安全性和耐受性。结果:共有55名男性完成了这项研究。在这55名男性中,有31名在左手术部位接受了罗哌卡因的滴注,而24名在右手术部位接受了罗哌卡因的滴注。罗哌卡因滴注的手术部位的VAS疼痛评分和PHPS显着低于术后2、4和8小时使用安慰剂获得的评分。一般而言,罗哌卡因的滴注是安全的,并且在患者中耐受性良好。结论:将罗哌卡因滴入腹股沟手术部位伤口可显着减轻显微精索静脉曲张切除术后的术后疼痛。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号